Lindsay A. Rosenwald MD - 18 Mar 2022 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)

Role
Director
Signature
/s/ Matthew Wein, Attorney-in-Fact
Issuer symbol
MBIO
Transactions as of
18 Mar 2022
Net transactions value
+$5,607
Form type
4
Filing time
03 Apr 2023, 16:50:59 UTC
Previous filing
25 Jul 2022
Next filing
24 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBIO COMMON STOCK, PAR VALUE $0.0001 Purchase $3,025 +4,094 +1.9% $0.7390 222,517 18 Mar 2022 Direct F1, F2
transaction MBIO COMMON STOCK, PAR VALUE $0.0001 Award $0 +71,664 +32% $0.000000 294,181 29 Jul 2022 Direct F2, F3
transaction MBIO COMMON STOCK, PAR VALUE $0.0001 Purchase $2,582 +5,000 +1.7% $0.5164 299,181 13 Sep 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan ("ESPP") during the ESPP offering period.
F2 Includes restricted share units, which vest over various time periods.
F3 The Reporting Person was granted 71,664 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 29, 2022. The shares will vest on June 17, 2025, subject to the Reporting Person's continued service on the Issuer's board on such date.